Forcutril Plus Cream is a potent topical formulation combining Ofloxacin (0.75% w/w), Ornidazole (2% w/w), Itraconazole (1% w/w), and Clobetasol (0.05% w/w) designed to effectively treat a variety of mixed infections involving bacteria, protozoa, fungi, and inflammatory skin conditions. Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, targets and inhibits bacterial DNA gyrase, thereby eliminating bacterial pathogens. Ornidazole, an antiprotozoal and antibacterial agent, is effective against anaerobic bacteria and protozoal infections. Itraconazole, a broad-spectrum antifungal agent, inhibits fungal cell membrane synthesis, combating dermatophytic and yeast infections. Clobetasol, a potent corticosteroid, provides anti-inflammatory, antipruritic, and vasoconstrictive effects, reducing redness, swelling, and itching associated with inflammatory dermatoses. The synergistic combination in Forcutril Plus Cream makes it suitable for managing complex skin infections where mixed microbial flora and inflammation coexist, such as infected eczema, dermatitis, or fungal-bacterial superinfections. It should be applied topically as directed by a healthcare professional, avoiding prolonged use to minimize potential side effects associated with corticosteroids. Patients should follow prescribed duration and frequency to ensure optimal therapeutic outcomes while monitoring for any adverse reactions. Forcutril Plus Cream offers a comprehensive approach to treating challenging dermatological infections with combined antimicrobial and anti-inflammatory action.